*Corresponding author:
Masoud Mirkazemi, Bone and Joint Reconstruction Research Centre, Shafa Orthopaedic Hospital, Iran University of Medical Sciences, Tehran, IranReceived: September 08, 2018; Published: September 18, 2018
DOI: 10.26717/BJSTR.2018.09.001753
To view the Full Article Peer-reviewed Article PDF
Soft Tissue Sarcoma (STS) is a rare neoplasm that accounts for 1% of all solid tumors in adults. In 2013, 11410 new cases were diagnosed in adults and children in the United States with 4,390 expected deaths [1].